AAAAAA
Results: 1-25/26
Authors:
STRAUS DJ
HUANG J
TESTA MA
LEVINE AM
KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA - ANALYSIS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-142 - LOW-DOSE VERSUS STANDARD-DOSE M-BACOD PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of clinical oncology, 16(11), 1998, pp. 3601-3606
Authors:
TESTA MA
SIMONSON DC
Citation: Ma. Testa et Dc. Simonson, HEALTH ECONOMIC-BENEFITS AND QUALITY-OF-LIFE DURING IMPROVED GLYCEMICCONTROL IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL, JAMA, the journal of the American Medical Association, 280(17), 1998, pp. 1490-1496
Authors:
SIMONSON DC
TESTA MA
Citation: Dc. Simonson et Ma. Testa, HEALTH-CARE EXPENDITURES DURING PROGRESSION FROM ORAL-AGENT TO INSULIN THERAPY IN TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 229-229
Authors:
SIMONSON DC
TESTA MA
Citation: Dc. Simonson et Ma. Testa, COST OF ORAL ANTIDIABETIC THERAPY IN PATIENTS WITH TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 231-231
Authors:
TESTA MA
TURNER RR
SIMONSON DC
Citation: Ma. Testa et al., EVALUATING PATIENT PREFERENCES FOR STATES OF HEALTH AND QUALITY-OF-LIFE IN PERSONS WITH TYPE-2 DIABETES, Diabetes, 47, 1998, pp. 1252-1252
Authors:
TESTA MA
TURNER RR
Citation: Ma. Testa et Rr. Turner, ASSESSMENT OF QUALITY-OF-LIFE IN HYPERTENSION AND ITS BEARING ON COMPLIANCE, International journal of clinical practice, 1997, pp. 19-22
Authors:
STRAUS DJ
HUANG J
TESTA MA
LEVINE AM
KAPLAN LD
Citation: Dj. Straus et al., PROGNOSTIC FACTORS IN THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN-LYMPHOMA (HANHL) - ANALYSIS OF ACTG-142 (LOW-DOSE VS STANDARD-DOSE MBACOD-CSF)(GM), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 89-89
Authors:
LENDERKING WR
TESTA MA
KATZENSTEIN D
HAMMER S
Citation: Wr. Lenderking et al., MEASURING QUALITY-OF-LIFE IN EARLY HIV DISEASE - THE MODULAR APPROACH, Quality of life research, 6(6), 1997, pp. 515-530
Authors:
CARROLL J
TESTA MA
ERAT K
LEBOFF MS
FULEIHAN GE
Citation: J. Carroll et al., MODELING FRACTURE RISK USING BONE-DENSITY, AGE, AND YEARS SINCE MENOPAUSE, American journal of preventive medicine, 13(6), 1997, pp. 447-452
Authors:
KROWN SE
TESTA MA
HUANG J
Citation: Se. Krown et al., AIDS-RELATED KAPOSIS-SARCOMA - PROSPECTIVE VALIDATION OF THE AIDS CLINICAL-TRIALS GROUP STAGING CLASSIFICATION, Journal of clinical oncology, 15(9), 1997, pp. 3085-3092
Authors:
LUQUE M
MANERO M
ESTEBAN E
TURNER RR
KRAFCIK MB
SIMONSON DC
TESTA MA
Citation: M. Luque et al., DIFFERENTIAL-EFFECTS OF CALCIUM-CHANNEL BLOCKERS ON PATIENT QUALITY-OF-LIFE - NIFEDIPINE GITS VS AMLODIPINE IN ESSENTIAL HYPERTENSIVES, Hypertension, 29(3), 1997, pp. 215-215
Authors:
KAPLAN LD
STRAUS DJ
TESTA MA
Citation: Ld. Kaplan et al., CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMAS - REPLY, The New England journal of medicine, 337(16), 1997, pp. 1173-1174
Authors:
KAPLAN LD
STRAUS DJ
TESTA MA
VONROENN J
DEZUBE BJ
COOLEY TP
HERNDIER B
NORTHFELT DW
HUANG J
TULPULE A
LEVINE AM
Citation: Ld. Kaplan et al., LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 336(23), 1997, pp. 1641-1648
Authors:
LENDERKING WR
NACKLEY JF
ANDERSON RB
TESTA MA
Citation: Wr. Lenderking et al., A REVIEW OF THE QUALITY-OF-LIFE ASPECTS OF URINARY URGE INCONTINENCE, PharmacoEconomics, 9(1), 1996, pp. 11-23
Authors:
TESTA MA
Citation: Ma. Testa, THE MEDICAL OUTCOMES STUDY, JAMA, the journal of the American Medical Association, 275(14), 1996, pp. 1083-1083
Authors:
TESTA MA
SIMONSON DC
Citation: Ma. Testa et Dc. Simonson, ASSESSMENT OF QUALITY-OF-LIFE - REPLY, The New England journal of medicine, 335(7), 1996, pp. 521-522
Authors:
TESTA MA
SIMONSON DC
Citation: Ma. Testa et Dc. Simonson, CURRENT CONCEPTS - ASSESSMENT OF QUALITY-OF-LIFE OUTCOMES, The New England journal of medicine, 334(13), 1996, pp. 835-840
Authors:
TESTA MA
SIMONSON DC
Citation: Ma. Testa et Dc. Simonson, BENEFICIAL-EFFECTS OF IMPROVED GLYCEMIC CONTROL WITH GLIPIZIDE GITS ON QUALITY-OF-LIFE AND SYMPTOMS IN NIDDM, Diabetologia, 39, 1996, pp. 878-878
Authors:
TESTA MA
SIMONSON DC
Citation: Ma. Testa et Dc. Simonson, BENEFICIAL-EFFECTS OF IMPROVED GLYCEMIC CONTROL GLIPIZIDE GITS ON QUALITY-OF-LIFE AND SYMPTOM DISTRESS IN NIDDM, Diabetes, 45, 1996, pp. 450-450
Authors:
FULEIHAN GEH
TESTA MA
ANGELL JE
PORRINO N
LEBOFF MS
Citation: Geh. Fuleihan et al., REPRODUCIBILITY OF DXA ABSORPTIOMETRY - A MODEL FOR BONE LOSS ESTIMATES, Journal of bone and mineral research, 10(7), 1995, pp. 1004-1014
Authors:
ANDRADE SE
WALKER AM
GOTTLIEB LK
HOLLENBERG NK
TESTA MA
SAPERIA GM
PLATT R
Citation: Se. Andrade et al., DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS, The New England journal of medicine, 332(17), 1995, pp. 1125-1131
Authors:
TESTA MA
NACKLEY JF
Citation: Ma. Testa et Jf. Nackley, METHODS FOR QUALITY-OF-LIFE STUDIES, Annual review of public health, 15, 1994, pp. 535-559
Authors:
LENDERKING WR
GELBER RD
COTTON DJ
COLE BF
GOLDHIRSCH A
VOLBERDING PA
TESTA MA
Citation: Wr. Lenderking et al., EVALUATION OF THE QUALITY-OF-LIFE ASSOCIATED WITH ZIDOVUDINE TREATMENT IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 330(11), 1994, pp. 738-743
Authors:
PARKER JD
TESTA MA
JIMENEZ AH
TOFLER GH
MULLER JE
PARKER JO
STONE PH
Citation: Jd. Parker et al., MORNING INCREASE IN AMBULATORY ISCHEMIA IN PATIENTS WITH STABLE CORONARY-ARTERY DISEASE - IMPORTANCE OF PHYSICAL-ACTIVITY AND INCREASED CARDIAC DEMAND, Circulation, 89(2), 1994, pp. 604-614
Authors:
TESTA MA
Citation: Ma. Testa, PARALLEL PERSPECTIVES ON QUALITY-OF-LIFE DURING ANTIHYPERTENSIVE THERAPY - IMPACT OF RESPONDER, SURVEY ENVIRONMENT, AND QUESTIONNAIRE STRUCTURE, Journal of cardiovascular pharmacology, 21, 1993, pp. 190000018-190000025